miR-146a promotes the initiation and progression of melanoma by activating Notch signaling
暂无分享,去创建一个
Michael R Green | Lihua Julie Zhu | Michael R. Green | Jianhong Ou | L. Zhu | M. Mahalingam | D. Conte | Jianhong Ou | S. Dogra | Meera Mahalingam | M. Forloni | A. Deng | N. Wajapeyee | Darryl Conte | Yuying Dong | Narendra Wajapeyee | Matteo Forloni | Shaillay Kumar Dogra | Yuying Dong | April Deng | Michael R. Green
[1] Y Taya,et al. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. , 2000, Genes & development.
[2] J. Woo,et al. A single nucleotide polymorphism in microRNA‐146a is associated with the risk for nasopharyngeal carcinoma , 2013, Molecular carcinogenesis.
[3] Katharina J Hoff,et al. The effect of sequencing errors on metagenomic gene prediction , 2009, BMC Genomics.
[4] L. Chin,et al. Malignant melanoma: genetics and therapeutics in the genomic era. , 2006, Genes & development.
[5] Robert A. Weinberg,et al. Ras oncogenes: split personalities , 2008, Nature Reviews Molecular Cell Biology.
[6] Hui-Kuan Lin,et al. Activation of Ras/PI3K/ERK pathway induces c-Myc stabilization to upregulate argininosuccinate synthetase, leading to arginine deiminase resistance in melanoma cells. , 2012, Cancer research.
[7] Barbara Jarzab,et al. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma , 2008, Proceedings of the National Academy of Sciences.
[8] J.,et al. The New England Journal of Medicine , 2012 .
[9] L. Chin,et al. Melanoma: from mutations to medicine. , 2012, Genes & development.
[10] A. Nicholson,et al. Mutations of the BRAF gene in human cancer , 2002, Nature.
[11] K. G. Guruharsha,et al. The Notch signalling system: recent insights into the complexity of a conserved pathway , 2012, Nature Reviews Genetics.
[12] Pu Li,et al. Genetic variants in miRNAs predict bladder cancer risk and recurrence. , 2012, Cancer research.
[13] D. Morrison,et al. MAP kinase pathways. , 2012, Cold Spring Harbor perspectives in biology.
[14] I. Behrmann,et al. Signatures of microRNAs and selected microRNA target genes in human melanoma. , 2010, Cancer research.
[15] Michael R Green,et al. HIV-1 Tat Stimulates Transcription Complex Assembly through Recruitment of TBP in the Absence of TAFs , 2005, PLoS biology.
[16] D. Schadendorf,et al. Somatic alterations in the melanoma genome: A high‐resolution array‐based comparative genomic hybridization study , 2010, Genes, chromosomes & cancer.
[17] Richard Marais,et al. The RAF proteins take centre stage , 2004, Nature Reviews Molecular Cell Biology.
[18] Matthew E Ritchie,et al. Using the R Package crlmm for Genotyping and Copy Number Estimation. , 2011, Journal of statistical software.
[19] T. Golde,et al. Rational targeting of Notch signaling in cancer , 2008, Oncogene.
[20] P. Sharp,et al. Function and localization of microRNAs in mammalian cells. , 2006, Cold Spring Harbor symposia on quantitative biology.
[21] Y. Jan,et al. Control of Daughter Cell Fates during Asymmetric Division: Interaction of Numb and Notch , 1996, Neuron.
[22] Lin He,et al. MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature Reviews Genetics.
[23] I. Umelo,et al. miR-146a Inhibits Cell Growth, Cell Migration and Induces Apoptosis in Non-Small Cell Lung Cancer Cells , 2013, PloS one.
[24] C. Croce. Causes and consequences of microRNA dysregulation in cancer , 2009, Nature Reviews Genetics.
[25] J. Handa,et al. Notch Signaling Promotes Growth and Invasion in Uveal Melanoma , 2012, Clinical Cancer Research.
[26] A. Capobianco,et al. Notch signalling in solid tumours: a little bit of everything but not all the time , 2011, Nature Reviews Cancer.
[27] S. Nishikawa,et al. Notch signaling via Hes1 transcription factor maintains survival of melanoblasts and melanocyte stem cells , 2006, The Journal of cell biology.
[28] M. Herlyn,et al. Normal human melanocyte homeostasis as a paradigm for understanding melanoma. , 2005, The journal of investigative dermatology. Symposium proceedings.
[29] Xavier Messeguer,et al. PROMO: detection of known transcription regulatory elements using species-tailored searches , 2002, Bioinform..
[30] L. Larue,et al. Melanoblasts' proper location and timed differentiation depend on Notch/RBP-J signaling in postnatal hair follicles. , 2008, The Journal of investigative dermatology.
[31] C. Croce,et al. MicroRNAs in Cancer. , 2009, Annual review of medicine.
[32] A. Leonardi,et al. Nuclear factor-{kappa}B contributes to anaplastic thyroid carcinomas through up-regulation of miR-146a. , 2010, The Journal of clinical endocrinology and metabolism.
[33] G. Sava,et al. Inhibition of the MEK/ERK signaling pathway by the novel antimetastatic agent NAMI-A down regulates c-myc gene expression and endothelial cell proliferation. , 2002, European journal of biochemistry.
[34] P. Linsley,et al. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice , 2011, The Journal of experimental medicine.
[35] S. Ogawa,et al. Both Notch1 and Notch2 contribute to the regulation of melanocyte homeostasis , 2007, Pigment cell & melanoma research.
[36] V. Ambros,et al. MicroRNAs and Other Tiny Endogenous RNAs in C. elegans , 2003, Current Biology.
[37] J. Nevins,et al. Ras enhances Myc protein stability. , 1999, Molecular cell.
[38] R. Lidereau,et al. Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers , 2011, EMBO molecular medicine.
[39] K. Flaherty,et al. Inhibition of mutated, activated BRAF in metastatic melanoma. , 2010, The New England journal of medicine.
[40] Kam Y. J. Zhang,et al. Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma , 2010, Nature.
[41] Jun S. Song,et al. Lineage-Specific Transcriptional Regulation of DICER by MITF in Melanocytes , 2010, Cell.
[42] C. Ciccarelli,et al. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors , 2006, Molecular Cancer.
[43] E. Furth,et al. The myc-miR-17~92 axis blunts TGF{beta} signaling and production of multiple TGF{beta}-dependent antiangiogenic factors. , 2010, Cancer research.
[44] P. Khavari,et al. Use of human tissue to assess the oncogenic activity of melanoma-associated mutations , 2005, Nature Genetics.
[45] Jean-Philippe Brunet,et al. The melanocyte differentiation program predisposes to metastasis after neoplastic transformation , 2005, Nature Genetics.
[46] Lin He,et al. MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature reviews genetics.
[47] P. Pollock,et al. Active Notch1 confers a transformed phenotype to primary human melanocytes. , 2009, Cancer research.
[48] M. Herlyn,et al. Activation of Notch1 signaling is required for beta-catenin-mediated human primary melanoma progression. , 2005, The Journal of clinical investigation.
[49] Y. Duan,et al. Cyclic stretch induced miR-146a upregulation delays C2C12 myogenic differentiation through inhibition of Numb. , 2009, Biochemical and biophysical research communications.
[50] R. Vyzula,et al. Evaluation of SNPs in miR-196-a2, miR-27a and miR-146a as risk factors of colorectal cancer. , 2012, World journal of gastroenterology.
[51] Chelsea C Pinnix,et al. Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression. , 2006, Cancer research.
[52] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[53] H. Rui,et al. ErbB2 Induces Notch1 Activity and Function in Breast Cancer Cells , 2008, Clinical and translational science.
[54] The rs2910164 G>C polymorphism in microRNA-146a is associated with the incidence of malignant melanoma , 2013, Melanoma research.
[55] Doron Betel,et al. Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas. , 2009, Genes & development.
[56] Shu-Chun Lin,et al. Association between the rs2910164 polymorphism in pre-mir-146a and oral carcinoma progression. , 2012, Oral oncology.
[57] J. Downward. Targeting RAS signalling pathways in cancer therapy , 2003, Nature Reviews Cancer.
[58] N. Hayward,et al. MicroRNA regulation of melanoma progression , 2012, Melanoma research.
[59] Tsung-Cheng Chang,et al. Widespread microRNA repression by Myc contributes to tumorigenesis , 2008, Nature Genetics.